What is the Optimal Rodent Model for Anti-tumor Drug Testing?

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Cancer Metastasis Review

• Publication date

  1998-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1023/A:1006152915959PMID 10352884
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Governing step of metastasis visualized in vitro.

  1997cited by this paper
• Cancer invasion and micrometastasis visualized in live tissue by green fluorescent protein expression.

  1997cited by this paper
• Antiangiogenic therapy of transgenic mice impairs de novo tumor growth.

  1996cited by this paper
• Impact of the cyclin–dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents

  1996cited by this paper
• Inhibition of human tumor xenograft growth by treatment with the farnesyl transferase inhibitor B956.

  1995cited by this paper
• Modulation of tumor cell gene expression and phenotype by the organspecific metastatic environment

  1995cited by this paper
• Implication of cell kinetic changes during the progression of human prostatic cancer.

  1995cited by this paper
• Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice

  1995cited by this paper
• Assessing new anti-tumour agents and strategies in oncogene transgenic mice

  1995cited by this paper
• Modulation of tumor cell response to chemotherapy by the organ environment

  1994cited by this paper
• Modulation of Doxorubicin sensitivity and level of p-glycoprotein expression in human colon-carcinoma cells by ectopic and orthotopic environments in nude-mice.

  1993cited by this paper
• Chemotherapy of mammary carcinomas arising in ras transgenic mice

  1993cited by this paper
• Orthotopic and ectopic organ environments differentially influence the sensitivity of murine colon carcinoma cells to doxorubicin and 5‐fluorouracil

  1992cited by this paper
• Glial cells and neurons induce blood-brain barrier related enzymes in cultured cerebral endothelial cells.

  1991cited by this paper
• The Nude Mouse in Oncology Research

  1991cited by this paper
• Responsiveness of subcutaneous human glioma xenografts to various antitumor agents.

  1990cited by this paper
• Evaluation of antitumor activity in a human breast tumor/nude mouse model with a special emphasis on treatment dose

  1989cited by this paper
• Responsiveness of Human Gastric Tumors Implanted in Nude Mice to Clinically Equivalent Doses of Various Antitumor Agents

  1988cited by this paper
• Clinical development of anticancer agents--a National Cancer Institute perspective.

  1984cited by this paper
• Second point: animal tumor models and their relevance to human tumor immunology.

  1983cited by this paper
• A critical examination of the foundations of immunotherapy for cancer.

  1979cited by this paper
• The choice of animal tumors for experimental studies of cancer therapy.

  1978cited by this paper
• A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin.

  1976cited by this paper

• Chemically Induced Brain Cancer in Sprague-Dawley Rats: Changed Lipidomics Mimics the Human Conditions

  2024cites this paper
• The chicken chorioallantoic membrane as a low-cost, high-throughput model for cancer imaging

  2023cites this paper
• Towards a better preclinical cancer model – human immune aging in humanized mice

  2023cites this paper
• Optimized splitting of mixed-species RNA sequencing data

  2022cites this paper
• Nanocarriers Call the Last Shot in the Treatment of Brain Cancers

  2022cites this paper
• Optimized splitting of RNA sequencing data by species

  2021cites this paper
• Intestinal stem cells and intestinal organoids.

  2020cites this paper
• Pigmented melanoma cell migration study on murine syngeneic B16F10 melanoma cells or tissue transplantation models

  2019cites this paper
• Engineering bone phenotypes in domestic animals: Unique resources for enhancing musculoskeletal research.

  2019cites this paper
• Perspective on the interpretation of research and translation to clinical care with therapy-associated metastatic breast cancer progression as an example

  2017cites this paper
• Mouse models of human disease

  2016cites this paper
• Mouse models of human disease evolutionary perspective

  2016cites this paper
• A Versatile Orthotopic Nude Mouse Model for Study of Esophageal Squamous Cell Carcinoma

  2015cites this paper
• Practical Applications of in Vivo and ex Vivo MRI in Toxicologic Pathology Using a Novel High-performance Compact MRI System

  2015cites this paper
• Antiangiogene Therapie in Kombination mit Temozolomid beim experimentellen MGMT-methylierten Glioblastom

  2013cites this paper
• Bioluminescence Imaging Correlates with Tumor Serum Marker, Organ Weights, Histology, and Human DNA Levels during Treatment of Orthotopic Tumor Xenografts with Antibodies

  2013cites this paper
• Multimodality imaging assessments of response to metformin therapy for breast cancer in nude mice

  2013cites this paper
• Neuroendocrine Tumors in an Orthotopic Xenograft Model Growth of Liver Metastases from Gastroenteropancreatic Targeting Aurora Kinases with Danusertib (PHA-739358) Inhibits

  2012cites this paper
• In vivo models of primary brain tumors: pitfalls and perspectives

  2012cites this paper
• Genetic Modification of Cancer Cells Using Non-Viral, Episomal S/MAR Vectors for In Vivo Tumour Modelling

  2012cites this paper
• Colon tumor growth and antivascular treatment in mice: complementary assessment with MR elastography and diffusion-weighted MR imaging.

  2012cites this paper
• Pharmacokinetics, dosimetry and comparative efficacy of 188Re-liposome and 5-FU in a CT26-luc lung-metastatic mice model.

  2012cites this paper
• Targeting Aurora Kinases with Danusertib (PHA-739358) Inhibits Growth of Liver Metastases from Gastroenteropancreatic Neuroendocrine Tumors in an Orthotopic Xenograft Model

  2012cites this paper
• The Ethics of Animal Research: Exploring the Controversy

  2012cites this paper
• Human Tumor Xenograft Efficacy Models

  2011cites this paper
• Mouse models of advanced spontaneous metastasis for experimental therapeutics

  2011cites this paper
• B16 Murine Melanoma: Historical Perspective on the Development of a Solid Tumor Model

  2011cites this paper
• An orthotopic, postsurgical model of luciferase transfected murine osteosarcoma with spontaneous metastasis

  2010cites this paper
• The laboratory opossum (Monodelphis domestica) as a natural mammalian model for human cancer research.

  2009cites this paper
• Comparative Impact of Trastuzumab and Cyclophosphamide on HER-2–Positive Human Breast Cancer Xenografts

  2009cites this paper
• MMP Inhibitor Clinical Trials – The Past, Present, and Future

  2008cites this paper
• Murine liver implantation of radiation-induced fibrosarcoma: characterization with MR imaging, microangiography and histopathology

  2008cites this paper
• Animal models of pancreatic cancer for drug research

  2008cites this paper
• Antitumor efficacy testing in rodents.

  2008cites this paper
• An update on the xenograft and mouse models suitable for investigating new therapeutic compounds for the treatment of B-cell malignancies.

  2008cites this paper
• EVALUATION OF HUMAN PROLACTIN, ITS ANTAGONIST, AND ANTAGONIST-BASED FUSION PROTEINS AS CHEMOPREVENTATIVE AND THERAPEUTIC AGENTS

  2007cites this paper
• In vivo models of childhood leukemia for preclinical drug testing.

  2007cites this paper
• Métabolisme énergétique au cours de la cachexie cancereuse

  2007cites this paper
• CANCER DRUG DISCOVERY AND DEVELOPMENT

  2007influential citation
• An Orthotopic Model of Pancreatic Somatostatin Receptor (SSTR)-Positive Tumors Allows Bimodal Imaging Studies Using 3T MRI and Animal PET-Based Molecular Imaging of SSTR Expression

  2007cites this paper
• Tumor Site Implantation and Animal Model Selection in Oncology

  2006cites this paper
• Reporter Gene System: Green Fluorescent Protein

  2006cites this paper
• Cancer Biology and Transgenic Technology in the Mouse

  2005cites this paper
• Mouse Models of Colorectal Cancer and Liver Metastases

  2005cites this paper
• In vivo echographic evidence of tumoral vascularization and microenvironment interactions in metastatic orthotopic human neuroblastoma xenografts

  2005cites this paper
• Tumour invasion and metastasis: challenges facing drug discovery.

  2005cites this paper
• Syngeneic mouse mammary carcinoma cell lines: Two closely related cell lines with divergent metastatic behavior

  2005cites this paper
• Mechanisms of bone invasion and metastasis in human neuroblastoma.

  2005cites this paper
• Modeling metastasis in vivo.

  2004cites this paper
• Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Does Not Improve Paclitaxel Effect in an Orthotopic Mouse Model of Lung Cancer

  2004cites this paper
• Trials, Tribulations, and Trends in Tumor Modeling in Mice

  2004cites this paper
• Modelling and Simulation in the Development and use of Anti-Cancer Agents: An Underused Tool?

  2004cites this paper
• Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis

  2004cites this paper
• Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1254 Application of a New Logic to Old Drugs: Angiogenesis Inhibition in Neuroblastoma

  2003cites this paper
• Combination of TRAIL gene therapy and chemotherapy enhances antitumor and antimetastasis effects in chemosensitive and chemoresistant breast cancers.

  2003cites this paper
• In vivo opossum xenograft model for cancer research.

  2003cites this paper
• Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models.

  2003cites this paper
• Advances in Brief In Vivo Opossum Xenograft Model for Cancer Research 1

  2003cites this paper
• Imaging of dihydrofolate reductase fusion gene expression in xenografts of human liver metastases of colorectal cancer in living rats

  2003cites this paper
• Human Tumor Xenografts as Predictive Preclinical Models for Anticancer Drug Activity in Humans: Better than Commonly Perceived—But They Can Be Improved

  2003cites this paper
• Matrix metalloproteinase inhibitors for cancer therapy: the current situation and future prospects

  2003cites this paper
• Acronycine derivatives as promising antitumor agents.

  2002cites this paper
• B16 Murine Melanoma

  2002cites this paper
• Comparison of the pharmacological profile of an olivacine derivative and a potential prodrug

  2002cites this paper
• CHAPTER 6 – ROLE OF MATRIX METALLOPROTEINASES AND PLASMINOGEN ACTIVATORS IN CANCER INVASION AND METASTASIS: THERAPEUTIC STRATEGIES

  2002cites this paper
• Defining the molecular and cellular basis of toxicity using comparative models.

  2002cites this paper
• Murine models for experimental therapy of pediatric solid tumors with poor prognosis

  2001cites this paper
• Refinement of an Orthotopic Lung Cancer Model in the Nude Rat

  2001cites this paper
• 2-Methoxyestradiol induces G2/M arrest and apoptosis in prostate cancer.

  2001cites this paper
• Isolation of Motile Tumor Cells from Live Breast Tumors

  2001cites this paper
• Green fluorescent protein as a marker for monitoring activity of stress-inducible hsp70 rat gene promoter

  2000cites this paper
• Assessing tumors in living animals through measurement of urinary β-human chorionic gonadotropin

  2000cites this paper
• Discovering novel chemotherapeutic drugs for the third millennium.

  1999cites this paper